Information Notice 2001-08, Supplment 2: Medical Device Safety Alert Issued, Following Radiation Therapy Overexposures in Panama, and Availability of the International Atomic Energy Agency Report: Difference between revisions
StriderTol (talk | contribs) Created page by program invented by StriderTol |
StriderTol (talk | contribs) StriderTol Bot change |
||
| Line 17: | Line 17: | ||
{{#Wiki_filter:UNITED STATES | {{#Wiki_filter:UNITED STATES | ||
NUCLEAR REGULATORY COMMISSION | ===NUCLEAR REGULATORY COMMISSION=== | ||
OFFICE OF NUCLEAR MATERIAL SAFETY AND SAFEGUARDS | |||
WASHINGTON, D.C. 20555-0001 | |||
===November 20, 2001=== | |||
NRC INFORMATION NOTICE 2001-08, SUPPLEMENT 2: | |||
===UPDATE ON RADIATION=== | |||
THERAPY OVEREXPOSURES | THERAPY OVEREXPOSURES | ||
| Line 35: | Line 38: | ||
notice (IN) 2001-08, to provide additional information related to the radiation therapy | notice (IN) 2001-08, to provide additional information related to the radiation therapy | ||
overexposures that recently occurred in Panama. All persons in your institution who are | overexposures that recently occurred in Panama. All persons in your institution who are | ||
involved with radiation therapy should review this notice. It is expected that recipients will | involved with radiation therapy should review this notice. It is expected that recipients will | ||
review this information for applicability to their facilities and consider actions, as appropriate, to | review this information for applicability to their facilities and consider actions, as appropriate, to | ||
avoid similar problems. However, suggestions contained in this IN are not new NRC | avoid similar problems. However, suggestions contained in this IN are not new NRC | ||
requirements; therefore, no specific action nor written response is required. | requirements; therefore, no specific action nor written response is required. | ||
| Line 50: | Line 53: | ||
Panama, involving radiation overexposures of 28 teletherapy patients, resulting in multiple | Panama, involving radiation overexposures of 28 teletherapy patients, resulting in multiple | ||
deaths. The International Atomic Energy Agency (IAEA) recently published its report entitled | deaths. The International Atomic Energy Agency (IAEA) recently published its report entitled | ||
Investigation of an Accidental Exposure of Radiotherapy Patients in Panama, which concluded | Investigation of an Accidental Exposure of Radiotherapy Patients in Panama, which concluded | ||
| Line 56: | Line 59: | ||
that the cause of the radiation overexposures was the way the shielding block data were | that the cause of the radiation overexposures was the way the shielding block data were | ||
entered into the computerized treatment planning system. The report is available from IAEA, | entered into the computerized treatment planning system. The report is available from IAEA, | ||
and can be ordered from its web site at: | and can be ordered from its web site at: | ||
http://www.iaea.org/worldatom/Books/NewReleases/book26.shtml. | http://www.iaea.org/worldatom/Books/NewReleases/book26.shtml. | ||
| Line 64: | Line 67: | ||
Corporation (Multidata), in St. Louis, Missouri, issued a Medical Device Safety Alert on | Corporation (Multidata), in St. Louis, Missouri, issued a Medical Device Safety Alert on | ||
June 22, 2001 (Attachment 1), and an Urgent Notice on August 10, 2001 (Attachment 2). The | June 22, 2001 (Attachment 1), and an Urgent Notice on August 10, 2001 (Attachment 2). The | ||
Urgent Notice explains that certain improper data entries will be accepted by the software, but | Urgent Notice explains that certain improper data entries will be accepted by the software, but | ||
will result in incorrect dose calculations. Multidata is developing a filter program to address | will result in incorrect dose calculations. Multidata is developing a filter program to address | ||
this problem. | this problem. | ||
| Line 82: | Line 85: | ||
IN 2001-08, Supp. 2 Specifically, the staff modified its procedures and entered data for multiple shielding blocks | IN 2001-08, Supp. 2 Specifically, the staff modified its procedures and entered data for multiple shielding blocks | ||
together (digitized the blocks), as if they were a single block. The data were accepted by the | together (digitized the blocks), as if they were a single block. The data were accepted by the | ||
treatment planning system, but the software calculated incorrect treatment times. Using | treatment planning system, but the software calculated incorrect treatment times. Using | ||
incorrect treatment times resulted in significant radiation overexposures to patients. The | incorrect treatment times resulted in significant radiation overexposures to patients. The | ||
hospital staff did not perform independent verification of the computer-calculated treatment | hospital staff did not perform independent verification of the computer-calculated treatment | ||
times, so the errors were not identified before treatment. The IAEA report states that there | times, so the errors were not identified before treatment. The IAEA report states that there | ||
were several characteristics of the computerized treatment planning system that made it | were several characteristics of the computerized treatment planning system that made it | ||
relatively easy for the error to occur. These were: | relatively easy for the error to occur. These were: | ||
1) | |||
Several different ways of digitizing blocks were accepted by the computer | |||
treatment planning system; | treatment planning system; | ||
2) | |||
There was no warning on the computer screen when blocks were digitized in an | |||
unacceptable way (i.e., any way that is different from the one prescribed in the | unacceptable way (i.e., any way that is different from the one prescribed in the | ||
| Line 104: | Line 109: | ||
manual); and | manual); and | ||
3) | 3) | ||
When blocks were digitized incorrectly, the treatment planning system produced | |||
a diagram that was the same as that produced when the data were entered | a diagram that was the same as that produced when the data were entered | ||
| Line 122: | Line 128: | ||
and written quality management program, required by 10 CFR 35.32, are adequate to avoid | and written quality management program, required by 10 CFR 35.32, are adequate to avoid | ||
similar radiation therapy errors. The event in Panama demonstrates that licensees should | similar radiation therapy errors. The event in Panama demonstrates that licensees should | ||
always be alert to the possibility of introducing unintended errors into the treatment planning | always be alert to the possibility of introducing unintended errors into the treatment planning | ||
process. In particular, note the importance of independent verification of computer-generated | process. In particular, note the importance of independent verification of computer-generated | ||
patient treatment plans. | patient treatment plans. | ||
| Line 132: | Line 138: | ||
In addition, if you are a Multidata customer, you should have received notices from the firm | In addition, if you are a Multidata customer, you should have received notices from the firm | ||
about this incident. If you have not received the attached communications from Multidata, you | about this incident. If you have not received the attached communications from Multidata, you | ||
should contact its Helpdesk at 1-800-225-1130 or helpdesk@multidata-systems.com. | should contact its Helpdesk at 1-800-225-1130 or helpdesk@multidata-systems.com. | ||
| Line 138: | Line 144: | ||
The U.S. Food and Drug Administration (FDA) is investigating this incident, and NRC is | The U.S. Food and Drug Administration (FDA) is investigating this incident, and NRC is | ||
cooperating with its investigation. Often device users are the first to discover problems with | cooperating with its investigation. Often device users are the first to discover problems with | ||
marketed medical devices. If you encounter device malfunctions or product problems involving | marketed medical devices. If you encounter device malfunctions or product problems involving | ||
| Line 147: | Line 153: | ||
through: | through: | ||
* | * | ||
* | Phone at 1-800-FDA-1088; | ||
* | |||
FAX at 1-800-FDA-0178; | |||
IN 2001-08, Supp. 2 * | IN 2001-08, Supp. 2 * | ||
* | The Internet at http://www.fda.gov/medwatch/ ; or, | ||
* | |||
Mailing your report to MedWatch, Food and Drug Administration, 5600 Fishers Lane | |||
(HF-2), Rockville, MD 20857. | (HF-2), Rockville, MD 20857. | ||
| Line 165: | Line 175: | ||
FDA's Center for Devices and Radiological Health, Office of Surveillance and Biometrics, through telephone at (301) 594-2735. | FDA's Center for Devices and Radiological Health, Office of Surveillance and Biometrics, through telephone at (301) 594-2735. | ||
This IN requires no specific action nor written response. If you have any questions about the | This IN requires no specific action nor written response. If you have any questions about the | ||
information in this notice, please contact one of the technical contacts listed below, or the | information in this notice, please contact one of the technical contacts listed below, or the | ||
| Line 171: | Line 181: | ||
appropriate NRC regional office. | appropriate NRC regional office. | ||
Donald A. Cool, Director | ===Donald A. Cool, Director=== | ||
Division of Industrial and | Division of Industrial and | ||
| Line 181: | Line 190: | ||
and Safeguards | and Safeguards | ||
Technical Contacts: | Technical Contacts: | ||
===Robert Ayres, NMSS=== | |||
Donna-Beth Howe, NMSS | |||
(301) 415-5746 | |||
(301) 415-7848 E-mail: rxa1@nrc.gov | |||
E-mail: dbh@nrc.gov | |||
Roberto J. Torres, NMSS | Roberto J. Torres, NMSS | ||
(301) 415-8112 E-mail: rjt@nrc.gov | (301) 415-8112 E-mail: rjt@nrc.gov | ||
Attachments: | Attachments: | ||
1. | 1. | ||
===Medical Device Safety Alert, June 22, 2001=== | |||
2. | |||
IN 2001-08, Supp. 2 * | ===Urgent Notice, August 10, 2001=== | ||
* | 3. | ||
===List of Recently Issued NMSS Information Notices=== | |||
4. | |||
===List of Recently Issued NRC Information Notices=== | |||
IN 2001-08, Supp. 2 * | |||
The Internet at http://www.fda.gov/medwatch/ ; or, | |||
* | |||
Mailing your report to MedWatch, Food and Drug Administration, 5600 Fishers Lane | |||
(HF-2), Rockville, MD 20857. | (HF-2), Rockville, MD 20857. | ||
| Line 211: | Line 236: | ||
FDA's Center for Devices and Radiological Health, Office of Surveillance and Biometrics, through telephone at (301) 594-2735. | FDA's Center for Devices and Radiological Health, Office of Surveillance and Biometrics, through telephone at (301) 594-2735. | ||
This IN requires no specific action nor written response. If you have any questions about the | This IN requires no specific action nor written response. If you have any questions about the | ||
information in this notice, please contact one of the technical contacts listed below, or the | information in this notice, please contact one of the technical contacts listed below, or the | ||
| Line 217: | Line 242: | ||
appropriate NRC regional office. | appropriate NRC regional office. | ||
Donald A. Cool, Director | ===Donald A. Cool, Director=== | ||
Division of Industrial and | Division of Industrial and | ||
| Line 227: | Line 251: | ||
and Safeguards | and Safeguards | ||
Technical Contacts: | Technical Contacts: | ||
(301) 415-5746 | ===Robert Ayres, NMSS=== | ||
Donna-Beth Howe, NMSS | |||
(301) 415-5746 | |||
(301) 415-7848 E-mail: rxa1@nrc.gov | |||
E-mail: dbh@nrc.gov | |||
Roberto J. Torres, NMSS | Roberto J. Torres, NMSS | ||
(301) 415-8112 E-mail: rjt@nrc.gov | (301) 415-8112 E-mail: rjt@nrc.gov | ||
Attachments: | Attachments: | ||
1. Medical Device Safety Alert, June 22, 2001 | 1. Medical Device Safety Alert, June 22, 2001 | ||
2. Urgent Notice, August 10, 2001 | 2. Urgent Notice, August 10, 2001 | ||
3. List of Recently Issued NMSS Information Notices | 3. List of Recently Issued NMSS Information Notices | ||
4. List of Recently Issued NRC Information Notices | 4. List of Recently Issued NRC Information Notices | ||
DOCUMENT NAME: | DOCUMENT NAME: | ||
| Line 246: | Line 276: | ||
Attachment 2) | Attachment 2) | ||
OFFICE | OFFICE | ||
MSIB | |||
C | |||
Editor | |||
N | |||
MSIB | |||
N | |||
MSIB | |||
IMNS | |||
N | |||
NAME | |||
Torres/Ayres | |||
EKraus/fax | |||
FBrown | |||
JHickey | |||
DCool | |||
DATE | |||
8/20/2001 & | |||
10/26/2001 | |||
8/24/2001 & | |||
11/6/2001 | |||
--------------- | |||
11/8/01 | |||
11/20/2001 | |||
===OFFICIAL RECORD COPY=== | |||
===Attachment 1=== | |||
IN 2001-08, Supp. 2 See ML012990318 | |||
===Attachment 1=== | |||
IN 2001-08, Supp. 2 See ML012990318 | |||
===Attachment 2=== | |||
IN 2001-08, Supp. 2 See ML012990328 | |||
===Attachment 2=== | |||
IN 2001-08, Supp. 2 See ML012990335 | |||
===Attachment 3=== | |||
IN 2001-08, Supp. 2 LIST OF RECENTLY ISSUED | |||
===NMSS INFORMATION NOTICES=== | |||
_____________________________________________________________________________________ | _____________________________________________________________________________________ | ||
Information | Information | ||
Date of | |||
Notice No. | |||
Subject | |||
Issuance | |||
Issued to | |||
_____________________________________________________________________________________ | _____________________________________________________________________________________ | ||
2001-11 | 2001-11 | ||
===Thefts of Portable Gauges=== | |||
07/13/2001 All portable Gauge licensees. | |||
2001-08, | |||
===Supplement 1=== | |||
Update on the Investigation of | |||
Patient Deaths in Panama, | |||
===Following Radiation Therapy=== | |||
Overexposures | Overexposures | ||
06/06/01 All medical licensees. | |||
2001-08 | |||
===Treatment Planning System=== | |||
Errors Result in Deaths of | Errors Result in Deaths of | ||
Overseas Radiation Therapy | ===Overseas Radiation Therapy=== | ||
Patients | |||
06/01/01 All medical licensees. | |||
2001-03 | 2001-03 | ||
Requirements for Radiography | ===Incident Reporting=== | ||
Requirements for Radiography | |||
Licensees | Licensees | ||
04/06/01 | |||
===All industrial radiography=== | |||
licensees. | |||
2001-01 | |||
===The Importance of Accurate=== | |||
Inventory Controls to Prevent | Inventory Controls to Prevent | ||
| Line 301: | Line 398: | ||
of Radioactive Material | of Radioactive Material | ||
03/26/01 All material licensees. | |||
2000-22 | |||
===Medical Misadministrations=== | |||
Caused by Human Errors | |||
Radiosurgery (GAMMA KNIFE) | ===Involving Gamma Stereotactic=== | ||
Radiosurgery (GAMMA KNIFE) | |||
12/18/00 | |||
===All medical use licensees=== | |||
authorized to conduct gamma | |||
stereotactic radiosurgery | |||
treatments. | |||
2000-19 | |||
===Implementation of Human Use=== | |||
Research Protocols Involving | Research Protocols Involving | ||
U.S. Nuclear Regulatory | ===U.S. Nuclear Regulatory=== | ||
Commission Regulated | Commission Regulated | ||
Materials | Materials | ||
12/05/2000 | |||
All medical use licensees. | |||
2000-18 | |||
Systems | ===Substandard Material Supplied=== | ||
by Chicago Bullet Proof | |||
Systems | |||
11/29/2000 | |||
===All 10 CFR Part 50 licensees and=== | |||
applicants. | |||
All | All category 1 fuel facilities. | ||
===All 10 CFR Part 72 licensees and=== | |||
applicants. | applicants. | ||
2000-16 | 2000-16 | ||
===Potential Hazards Due to=== | |||
Volatilization of Radionuclides | |||
10/5/2000 | |||
===All licensees that process=== | |||
unsealed byproduct material. | |||
2000-15 | |||
===Recent Events Resulting in=== | |||
Whole Body Exposures | Whole Body Exposures | ||
Exceeding Regulatory Limits | ===Exceeding Regulatory Limits=== | ||
9/29/2000 | |||
All radiography licensees. | |||
______________________________________________________________________________________ | |||
OL = Operating License | |||
CP = Construction Permit | |||
===Attachment 4=== | |||
IN 2001-08, Supp. 2 LIST OF RECENTLY ISSUED | |||
===NRC INFORMATION NOTICES=== | |||
_____________________________________________________________________________________ | _____________________________________________________________________________________ | ||
Information | Information | ||
Date of | |||
Notice No. | |||
Subject | |||
Issuance | |||
Issued to | |||
______________________________________________________________________________________ | ______________________________________________________________________________________ | ||
2001-16 | 2001-16 | ||
===Recent Foreign and Domestic=== | |||
Experience with Degradation of | |||
steam Generator Tubes and | |||
Internals | |||
10/31/2001 | |||
===All holders of operating licenses=== | |||
for pressurized-water reactors | |||
(PWR), except those who have | |||
permanently ceased operations | |||
and have certified that fuel has | and have certified that fuel has | ||
| Line 363: | Line 512: | ||
the reactor | the reactor | ||
2001-15 | 2001-15 Non-Conservative Errors in | ||
Minimum Critical Power Ratio | ===Minimum Critical Power Ratio=== | ||
Limits | |||
10/29/01 | |||
Installed Swing-Check Valves | ===All holders of operating licenses=== | ||
or construction permits for boiling | |||
water reactors (BWRs) | |||
2001-14 Problems with Incorrectly- Installed Swing-Check Valves | |||
10/03/01 | |||
===All holders of operating licenses=== | |||
or construction permits for nuclear | |||
power reactors except those who | power reactors except those who | ||
| Line 382: | Line 540: | ||
reactor vessel | reactor vessel | ||
2001-13 | 2001-13 | ||
Control System Relief Valve | ===Inadequate Standby Liquid=== | ||
Control System Relief Valve | |||
Margin | Margin | ||
08/10/01 | |||
===All holders of operating licenses=== | |||
for boiling water reactors | |||
2001-12 (ERRATA) | |||
===Hydrogen Fire at Nuclear=== | |||
Power Stations | |||
8/08/01 | |||
===All holders of operating licenses=== | |||
or construction permits for nuclear | |||
power reactors except those who | power reactors except those who | ||
| Line 402: | Line 572: | ||
reactor vessel | reactor vessel | ||
2001-12 | 2001-12 | ||
Power Stations | ===Hydrogen Fire at Nuclear=== | ||
Power Stations | |||
7/13/01 | |||
===All holders of operating licenses=== | |||
or construction permits for nuclear | |||
power reactors except those who | power reactors except those who | ||
| Line 414: | Line 590: | ||
permanently removed from the | permanently removed from the | ||
reactor vessel | reactor vessel}} | ||
{{Information notice-Nav}} | {{Information notice-Nav}} | ||
Latest revision as of 01:50, 17 January 2025
| ML012390161 | |
| Person / Time | |
|---|---|
| Issue date: | 11/20/2001 |
| From: | Cool D NRC/NMSS/IMNS |
| To: | |
| Torres R, NMSS/IMNS, 415-8112 | |
| References | |
| FOIA/PA-2002-0061 IN-01-008, Suppl 2 | |
| Download: ML012390161 (13) | |
UNITED STATES
NUCLEAR REGULATORY COMMISSION
OFFICE OF NUCLEAR MATERIAL SAFETY AND SAFEGUARDS
WASHINGTON, D.C. 20555-0001
November 20, 2001
NRC INFORMATION NOTICE 2001-08, SUPPLEMENT 2:
UPDATE ON RADIATION
THERAPY OVEREXPOSURES
IN PANAMA
Addressees
All medical licensees.
Purpose
The U.S. Nuclear Regulatory Commission (NRC) is issuing this supplement to information
notice (IN) 2001-08, to provide additional information related to the radiation therapy
overexposures that recently occurred in Panama. All persons in your institution who are
involved with radiation therapy should review this notice. It is expected that recipients will
review this information for applicability to their facilities and consider actions, as appropriate, to
avoid similar problems. However, suggestions contained in this IN are not new NRC
requirements; therefore, no specific action nor written response is required.
Description of Circumstances
IN 2001-08, dated June 1, 2001, and Supplement 1, dated June 6, 2001, describe an incident in
Panama, involving radiation overexposures of 28 teletherapy patients, resulting in multiple
deaths. The International Atomic Energy Agency (IAEA) recently published its report entitled
Investigation of an Accidental Exposure of Radiotherapy Patients in Panama, which concluded
that the cause of the radiation overexposures was the way the shielding block data were
entered into the computerized treatment planning system. The report is available from IAEA,
and can be ordered from its web site at:
http://www.iaea.org/worldatom/Books/NewReleases/book26.shtml.
The company that supplied the treatment planning software, Multidata Systems International
Corporation (Multidata), in St. Louis, Missouri, issued a Medical Device Safety Alert on
June 22, 2001 (Attachment 1), and an Urgent Notice on August 10, 2001 (Attachment 2). The
Urgent Notice explains that certain improper data entries will be accepted by the software, but
will result in incorrect dose calculations. Multidata is developing a filter program to address
this problem.
Discussion
According to the IAEA report, one method the Panamanian hospital staff used for the data entry
of shielding blocks caused the treatment planning system to calculate incorrect treatment times.
IN 2001-08, Supp. 2 Specifically, the staff modified its procedures and entered data for multiple shielding blocks
together (digitized the blocks), as if they were a single block. The data were accepted by the
treatment planning system, but the software calculated incorrect treatment times. Using
incorrect treatment times resulted in significant radiation overexposures to patients. The
hospital staff did not perform independent verification of the computer-calculated treatment
times, so the errors were not identified before treatment. The IAEA report states that there
were several characteristics of the computerized treatment planning system that made it
relatively easy for the error to occur. These were:
1)
Several different ways of digitizing blocks were accepted by the computer
treatment planning system;
2)
There was no warning on the computer screen when blocks were digitized in an
unacceptable way (i.e., any way that is different from the one prescribed in the
manual); and
3)
When blocks were digitized incorrectly, the treatment planning system produced
a diagram that was the same as that produced when the data were entered
correctly, thereby giving the impression that the calculated results were correct.
The Multidata Medical Device Safety Alert, dated June 22, 2001, urges customers to follow
the instructions in the user manual, and emphasizes that users should not attempt to operate
the system outside the limitations stated in the user manual.
All persons involved in radiation therapy are encouraged to review both the information related
to this incident, and your treatment planning procedures, to ensure that both your procedures
and written quality management program, required by 10 CFR 35.32, are adequate to avoid
similar radiation therapy errors. The event in Panama demonstrates that licensees should
always be alert to the possibility of introducing unintended errors into the treatment planning
process. In particular, note the importance of independent verification of computer-generated
patient treatment plans.
In addition, if you are a Multidata customer, you should have received notices from the firm
about this incident. If you have not received the attached communications from Multidata, you
should contact its Helpdesk at 1-800-225-1130 or helpdesk@multidata-systems.com.
The U.S. Food and Drug Administration (FDA) is investigating this incident, and NRC is
cooperating with its investigation. Often device users are the first to discover problems with
marketed medical devices. If you encounter device malfunctions or product problems involving
radiation therapy devices or radiation therapy treatment planning systems, particularly those
that may be software related, you are strongly encouraged to report such events to MedWatch, the FDAs voluntary reporting program. You may submit voluntary reports to MedWatch
through:
Phone at 1-800-FDA-1088;
FAX at 1-800-FDA-0178;
IN 2001-08, Supp. 2 *
The Internet at http://www.fda.gov/medwatch/ ; or,
Mailing your report to MedWatch, Food and Drug Administration, 5600 Fishers Lane
(HF-2), Rockville, MD 20857.
Also note that under the Safe Medical Devices Act of 1990, user facilities must comply with
specific, mandatory reporting time frames and requirements, when they become aware that a
medical device may have caused, or contributed to, a patient death or serious injury/illness.
Questions concerning FDA's mandatory user facility reporting requirements can be directed to
FDA's Center for Devices and Radiological Health, Office of Surveillance and Biometrics, through telephone at (301) 594-2735.
This IN requires no specific action nor written response. If you have any questions about the
information in this notice, please contact one of the technical contacts listed below, or the
appropriate NRC regional office.
Donald A. Cool, Director
Division of Industrial and
Medical Nuclear Safety
Office of Nuclear Material Safety
and Safeguards
Technical Contacts:
Robert Ayres, NMSS
(301) 415-5746
(301) 415-7848 E-mail: rxa1@nrc.gov
E-mail: dbh@nrc.gov
Roberto J. Torres, NMSS
(301) 415-8112 E-mail: rjt@nrc.gov
Attachments:
1.
Medical Device Safety Alert, June 22, 2001
2.
Urgent Notice, August 10, 2001
3.
List of Recently Issued NMSS Information Notices
4.
List of Recently Issued NRC Information Notices
IN 2001-08, Supp. 2 *
The Internet at http://www.fda.gov/medwatch/ ; or,
Mailing your report to MedWatch, Food and Drug Administration, 5600 Fishers Lane
(HF-2), Rockville, MD 20857.
Also note that under the Safe Medical Devices Act of 1990, user facilities must comply with
specific, mandatory reporting time frames and requirements, when they become aware that a
medical device may have caused, or contributed to, a patient death or serious injury/illness.
Questions concerning FDA's mandatory user facility reporting requirements can be directed to
FDA's Center for Devices and Radiological Health, Office of Surveillance and Biometrics, through telephone at (301) 594-2735.
This IN requires no specific action nor written response. If you have any questions about the
information in this notice, please contact one of the technical contacts listed below, or the
appropriate NRC regional office.
Donald A. Cool, Director
Division of Industrial and
Medical Nuclear Safety
Office of Nuclear Material Safety
and Safeguards
Technical Contacts:
Robert Ayres, NMSS
(301) 415-5746
(301) 415-7848 E-mail: rxa1@nrc.gov
E-mail: dbh@nrc.gov
Roberto J. Torres, NMSS
(301) 415-8112 E-mail: rjt@nrc.gov
Attachments:
1. Medical Device Safety Alert, June 22, 2001
2. Urgent Notice, August 10, 2001
3. List of Recently Issued NMSS Information Notices
4. List of Recently Issued NRC Information Notices
DOCUMENT NAME:
Package ML012990347 contains ML012390161 (Information Notice text), ML012990318 (Attachment 1), ML012990328 (Page 1 of Attachment 2) and ML012990335 (Page 2 of
Attachment 2)
OFFICE
MSIB
C
Editor
N
MSIB
N
MSIB
IMNS
N
NAME
Torres/Ayres
EKraus/fax
FBrown
JHickey
DCool
DATE
8/20/2001 &
10/26/2001
8/24/2001 &
11/6/2001
11/8/01
11/20/2001
OFFICIAL RECORD COPY
Attachment 1
IN 2001-08, Supp. 2 See ML012990318
Attachment 1
IN 2001-08, Supp. 2 See ML012990318
Attachment 2
IN 2001-08, Supp. 2 See ML012990328
Attachment 2
IN 2001-08, Supp. 2 See ML012990335
Attachment 3
IN 2001-08, Supp. 2 LIST OF RECENTLY ISSUED
NMSS INFORMATION NOTICES
_____________________________________________________________________________________
Information
Date of
Notice No.
Subject
Issuance
Issued to
_____________________________________________________________________________________
2001-11
Thefts of Portable Gauges
07/13/2001 All portable Gauge licensees.
2001-08,
Supplement 1
Update on the Investigation of
Patient Deaths in Panama,
Following Radiation Therapy
06/06/01 All medical licensees.
2001-08
Treatment Planning System
Errors Result in Deaths of
Overseas Radiation Therapy
Patients
06/01/01 All medical licensees.
2001-03
Incident Reporting
Requirements for Radiography
Licensees
04/06/01
All industrial radiography
licensees.
2001-01
The Importance of Accurate
Inventory Controls to Prevent
the Unauthorized Possession
of Radioactive Material
03/26/01 All material licensees.
2000-22
Medical Misadministrations
Caused by Human Errors
Involving Gamma Stereotactic
Radiosurgery (GAMMA KNIFE)
12/18/00
All medical use licensees
authorized to conduct gamma
stereotactic radiosurgery
treatments.
2000-19
Implementation of Human Use
Research Protocols Involving
U.S. Nuclear Regulatory
Commission Regulated
Materials
12/05/2000
All medical use licensees.
2000-18
Substandard Material Supplied
by Chicago Bullet Proof
Systems
11/29/2000
All 10 CFR Part 50 licensees and
applicants.
All category 1 fuel facilities.
All 10 CFR Part 72 licensees and
applicants.
2000-16
Potential Hazards Due to
Volatilization of Radionuclides
10/5/2000
All licensees that process
unsealed byproduct material.
2000-15
Recent Events Resulting in
Whole Body Exposures
Exceeding Regulatory Limits
9/29/2000
All radiography licensees.
______________________________________________________________________________________
OL = Operating License
CP = Construction Permit
Attachment 4
IN 2001-08, Supp. 2 LIST OF RECENTLY ISSUED
NRC INFORMATION NOTICES
_____________________________________________________________________________________
Information
Date of
Notice No.
Subject
Issuance
Issued to
______________________________________________________________________________________
2001-16
Recent Foreign and Domestic
Experience with Degradation of
steam Generator Tubes and
Internals
10/31/2001
All holders of operating licenses
for pressurized-water reactors
(PWR), except those who have
permanently ceased operations
and have certified that fuel has
been permanently removed from
the reactor
2001-15 Non-Conservative Errors in
Minimum Critical Power Ratio
Limits
10/29/01
All holders of operating licenses
or construction permits for boiling
water reactors (BWRs)
2001-14 Problems with Incorrectly- Installed Swing-Check Valves
10/03/01
All holders of operating licenses
or construction permits for nuclear
power reactors except those who
have ceased operations and have
certified that fuel has been
permanently removed from the
reactor vessel
2001-13
Inadequate Standby Liquid
Control System Relief Valve
Margin
08/10/01
All holders of operating licenses
for boiling water reactors
2001-12 (ERRATA)
Hydrogen Fire at Nuclear
Power Stations
8/08/01
All holders of operating licenses
or construction permits for nuclear
power reactors except those who
have ceased operations and have
certified that fuel has been
permanently removed from the
reactor vessel
2001-12
Hydrogen Fire at Nuclear
Power Stations
7/13/01
All holders of operating licenses
or construction permits for nuclear
power reactors except those who
have ceased operations and have
certified that fuel has been
permanently removed from the
reactor vessel